SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-427782
Filing Date
2014-11-28
Accepted
2014-11-28 08:39:34
Documents
6
Period of Report
2014-11-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d830321d8k.htm 8-K 21866
2 EX-3.6 d830321dex36.htm EX-3.6 79587
3 EX-3.7 d830321dex37.htm EX-3.7 2175
4 EX-10.56 d830321dex1056.htm EX-10.56 77916
5 EX-99.1 d830321dex991.htm EX-99.1 6917
6 GRAPHIC g830321ex99_1pg01.jpg GRAPHIC 15825
  Complete submission text file 0001193125-14-427782.txt   211675
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 6789905740
ALIMERA SCIENCES INC (Filer) CIK: 0001267602 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34703 | Film No.: 141254998
SIC: 2834 Pharmaceutical Preparations